CPT copyright 2013 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.Anesthesiologists often ...
This transcript has been edited for clarity. Jeff Gadsden, MD: Hello, I'm Dr Jeff Gadsden, a professor of anesthesiology at Duke University Hospital in North Carolina. And with me is Dr Eliana ...
New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...
Intravenous lidocaine infusion has emerged as a promising adjunct for postoperative pain management, offering a potential alternative to conventional opioid‐based strategies and regional techniques ...
This Collection invites original research on postoperative pain management, from studies examining strategies for preventing and assessing postoperative pain to those exploring delivery of pain ...
—Because moderate or severe pain is common after surgery, and can hinder postoperative outcomes, it’s critical that care teams have recommendations that can facilitate pain management throughout the ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from a Phase 4 study of JOURNAVX ® (suzetrigine), a prescription non-opioid pain signal inhibitor for the treatment of ...
A sweeping review of previous research suggests commonly prescribed opioids often provide only modest pain relief and may increase side effect risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results